GC
DXCM icon

Globeflex Capital’s DexCom DXCM Stock Holding History

Globeflex Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-83,800
Closed -$866K – 625
2014
Q1 		$866K Sell
83,800
-600
-0.7% -$6.2K 0.1% 238
2013
Q4 		$747K Buy
+84,400
New +$668K 0.09% 251

Other funds holding DXCM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Globeflex Capital's DXCM Position: Q2 2014 in Review

Globeflex Capital sold out of DexCom (DXCM) in Q2 2014, closing a stake of 83,800 shares — an estimated $866K sold.

Globeflex Capital first reported a position in DXCM in Q4 2013 and held it in 2 quarters. The position peaked at $866K in Q1 2014. 190 funds tracked by Wall St. Rank hold DXCM as of Q2 2014.

  • Globeflex Capital reported no remaining DexCom position as of Q2 2014 after selling out during the quarter.
  • Globeflex Capital sold 83,800 DexCom shares in Q2 2014, an estimated $866K.
  • Globeflex Capital first reported a position in DexCom in Q4 2013 and held it in 2 quarters.
  • Globeflex Capital's DexCom position peaked at $866K in Q1 2014.
  • 190 funds tracked by Wall St. Rank held DexCom as of Q2 2014.

Based on Globeflex Capital's 13F filing for Q2 2014, filed 18 Jul 2014.